Table 3. Table 3. Histopathological outcome (a) per patient and per sentinel lymph node and (b) sentinel lymph node identification of involved nodes using radiosiotope or Patent Blue V.

(a)*	Per patient n (%)	Per sentinel lymph node n (%)
Normal	116 (72.5%)	288 (84.2%)
ITC	9 (5.6%)	11 (3.2%)
Micro	15 (9.4%)	18 (5.3%)
Macro	20 (12.5%)	25 (7.3%)

^*ITC: isolated tumour cells, micro: micro-metastases, macro: macro-metastases.